Mифортик (Mycophenolic Acid)

Mycophenolic Acid blocks the enzyme inosine monophosphate dehydrogenase, which is essential for making guanosine nucleotides in lymphocytes. This inhibition stops the proliferation of T‑ and B‑cells, thereby reducing the immune response that can cause graft rejection or autoimmune tissue damage.

The dosage of Mифортик is individualized. A qualified prescriber determines the appropriate amount based on the patient’s condition, weight, kidney function, and other medications. Patients should follow the prescribing physician’s instructions and not adjust the dose on their own.

The safety of Mycophenolic Acid in pregnancy and lactation is not established. It is generally avoided because of potential fetal toxicity. Women of child‑bearing potential should use effective contraception, and breastfeeding mothers should discuss risks with their healthcare provider.

To order Mифортик, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to Mycophenolic Acid is azathioprine, another immunosuppressant. Mycophenolic Acid offers more selective inhibition of lymphocyte proliferation and often provides better graft‑survival rates, but it may have a higher incidence of gastrointestinal side effects. Choice depends on patient tolerance, organ type and physician preference.

Mифортик should be stored at temperatures below 25 °C in a dry place. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Mифортик is taken orally, usually with food or a glass of water to lessen stomach irritation. The tablets are swallowed whole; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

Serious risks include bone‑marrow suppression leading to anemia or infections, severe opportunistic infections, liver toxicity, and a possible increased risk of certain cancers. Patients should report persistent fever, unusual bruising, jaundice, or unexplained weight loss to their physician promptly.

Mифортик is contraindicated in patients with known hypersensitivity to Mycophenolic Acid, those with active severe infections, and individuals who are pregnant unless the benefit outweighs the risk. Caution is also advised for patients with significant renal or hepatic impairment.